Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review
Justin P. Reinert, Kayla N. Colunga, Alexandria Etuk, Victoria Richardson, Rebecca L. Dunn
Expert Review of Clinical Pharmacology July 10, 2020 DOI: 10.1080/17512433.2020.1794811 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Health care Cinahl Traditional medicine Intensive care medicine Hallucinogen Psychological intervention Alkaloids |
| Citations | 11 |
| Key findings | Clinicians should consider salvia, kratom, and psilocybin mushrooms as potential etiologies in overdose scenarios due to increased global use, though such overdoses are not typically fatal. |
Abstract
Salvia, kratom, and psilocybin mushrooms may not be an initial consideration when healthcare practitioners are triaging an overdose scenario; however, data from around the world demonstrate an increased use of these agents. While not typically fatal, clinicians must be prepared to assess these as a potential etiology of overdoses and provide appropriate supportive care.